loading page

Secondary biphenotypic leukemia following Rosai-Dorfman-Disease A coincidence?
  • +10
  • Anne Thieme,
  • Katja Maurus,
  • Karen Ernestus,
  • Steffen Hirsch,
  • Kathrin Schramm,
  • Clemens Benoit,
  • Andreas Buck,
  • Christoph Haertel,
  • Paul Schlegel,
  • Matthias Eyrich,
  • Matthias Wölfl,
  • Carl-Friedrich Classen,
  • Verena Wiegering
Anne Thieme
University of Würzburg

Corresponding Author:[email protected]

Author Profile
Katja Maurus
University of Würzburg
Author Profile
Karen Ernestus
University of Würzburg
Author Profile
Steffen Hirsch
University of Heidelberg Medical Clinic Medical and Scientific Library
Author Profile
Kathrin Schramm
University of Heidelberg Medical Clinic Medical and Scientific Library
Author Profile
Clemens Benoit
University of Würzburg
Author Profile
Andreas Buck
University of Würzburg
Author Profile
Christoph Haertel
University of Würzburg
Author Profile
Paul Schlegel
University Hospital of Wuerzburg
Author Profile
Matthias Eyrich
Julius-Maximilians-Universitat Wurzburg
Author Profile
Matthias Wölfl
University Hospital of Wuerzburg
Author Profile
Carl-Friedrich Classen
University Hospital Rostock
Author Profile
Verena Wiegering
University of Würzburg
Author Profile

Abstract

Rosai-Dorman-Disease is one subgroup of Non-Langerhans cell histiocytosis with massive lymphadenopathy. It is a generally a benign and self-limiting disease, but an association to hemato-lymphoid malignancies or immune diseases is suspected. We present the case of a 6-year old male patient with multifocal extranodal RDD developing a secondary biphenotypic, treatment-resistant leukemia during treatment. Hypothysing that RDD and the secondary leukemia could be based on the same malign clone or on a cancer predispostion syndrome, whole-exome-sequencing of a saliva sample and leukemic cells were performed. A common marker of cell lines of histiocytosis and leukemic blasts has not been found.